DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 04 · Volume 31 · July 1998 DOI: 10.1055/s-002-6318

Original Papers

117
Sandmann, J.; Lörch, B.; Bandelow, B.; Härtter, S.; Winter, P.; Hiemke, C.; Benkert, O.: Fluvoxamine or Placebo in the Treatment of Panic Disorder and Relationship to Blood Concentrations of Fluvoxamine
122
Dose, M.; Hellweg, R.; Yassouridis, A.; Theison, M.; Emrich, H. M.: Combined Treatment of Schizophrenic Psychoses with Haloperidol and Valproate
126
Hatta, K.; Takahashi, T.; Nakamura, H.; Yamashiro, H.; Endo, H.; Kito, K.; Saeki, T.; Masui, K.; Yonezawa, Y.: A Risk for Obstruction of the Airways in the Parenteral Use of Levomepromazine with Benzodiazepine
131
Santagostino, G.; Cucchi, Maria Laura; Frattini, P.; Zerbi, F.; Di Paolo, E.; Preda, Stefania; Corona, G. L.: The Influence of Alprazolam on the Monoaminergic Neurotransmitter Systems in Dysthymic Patients. Relationship to Clinical Response

Case Reports

143
Bonnet, U.; Banger, M.; Wolstein, J.; Gastpar, M.: Choreoathetoid Movements Associated with Rapid Adjustment to Methadone
146
Jauss, M.; Schröder, J.; Pantel, J.; Bachmann, S.; Gerdsen, I.; Mundt, Ch.: Severe Akathisia during Olanzapine Treatment of Acute Schizophrenia
149
152
Braun, J. S.; Geiger, R.; Wehner, H.; Schäffer, S.; Berger, M.: Hepatitis Caused by Antidepressive Therapy with Maprotiline and Opipramol
156